ClinicalTrials.Veeva

Menu

Hydrocodone Compared to Acetaminophen and Ibuprofen for Post-nail Procedure Analgesia

Weill Cornell Medicine (WCM) logo

Weill Cornell Medicine (WCM)

Status and phase

Completed
Phase 4

Conditions

Nail Abnormality
Nail Diseases

Treatments

Drug: Acetaminophen 1000mg
Drug: Ibuprofen 400 mg
Drug: Hydrocodone 5Mg/Acetaminophen 325Mg Tab

Study type

Interventional

Funder types

Other

Identifiers

NCT05544734
21-10024054

Details and patient eligibility

About

The purpose of this study is to assess the safety and efficacy of ropivacaine and hydrocodone for nail-procedure associated pain management. The investigators hypothesize that ropivacaine with hydrocodone will be superior to ropivacaine with acetaminophen and ibuprofen for managing pain.

Enrollment

20 patients

Sex

All

Ages

18 to 95 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing fingernail or toenail, excision, or shave biopsy
  • Must understand and voluntarily sign an informed consent form
  • Must be male or female and aged 18-95 years at time of consent
  • Must be able to adhere to the study visit schedule and other protocol requirements

Exclusion criteria

  • Subject is unable to provide written informed consent for any reason
  • Subject has peripheral vascular disease, arterial insufficiency, peripheral neuropathy
  • Subject is on Aspirin, NSAIDs, or consumes a chronic medication for control of any other chronic pain
  • Subject has a history of opioid or alcohol use disorder
  • Subject has a history of peptic ulcer disease, gastritis, chronic renal insufficiency or a history of kidney disease, or has underlying liver disease
  • Subject has a history of severe constipation
  • Subject is sensitive or allergic to any of the elements included in this study
  • Subject is unable to complete the required pain dairy
  • Subject is pregnant, planning pregnancy, or nursing

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

20 participants in 2 patient groups

Hydrocodone 5mg/acetaminophen 325mg
Active Comparator group
Description:
Participants receive oral hydrocodone 5 mg/acetaminophen 325 mg every 4 hours for 2 days, followed by oral acetaminophen 1000 mg and oral ibuprofen 400 mg every 6 hours for 4 days
Treatment:
Drug: Hydrocodone 5Mg/Acetaminophen 325Mg Tab
Drug: Ibuprofen 400 mg
Drug: Acetaminophen 1000mg
Acetaminophen 1000mg + Ibuprofen 400mg
Active Comparator group
Description:
Participants receive oral acetaminophen 1000 mg and oral ibuprofen 400 mg every 6 hours for 6 days
Treatment:
Drug: Ibuprofen 400 mg
Drug: Acetaminophen 1000mg

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems